These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12483094)

  • 1. A comparative clinical study of latanoprost and isopropyl unoprostone in Japanese patients with primary open-angle glaucoma and ocular hypertension.
    Tsukamoto H; Mishima HK; Kitazawa Y; Araie M; Abe H; Negi A;
    J Glaucoma; 2002 Dec; 11(6):497-501. PubMed ID: 12483094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension.
    Susanna R; Giampani J; Borges AS; Vessani RM; Jordao ML
    Ophthalmology; 2001 Feb; 108(2):259-63. PubMed ID: 11158796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%.
    Stewart WC; Sharpe ED; Stewart JA; Holmes KT; Latham KE
    Am J Ophthalmol; 2001 Mar; 131(3):339-44. PubMed ID: 11239866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension.
    Aung T; Chew PT; Yip CC; Chan YH; See JL; Khng CG; Hoh ST; Ng LH; Lee HM
    Am J Ophthalmol; 2001 May; 131(5):636-42. PubMed ID: 11336940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure.
    Aung T; Chew PT; Oen FT; Chan YH; Thean LH; Yip L; Lim BA; Soh J; Seah SK
    Br J Ophthalmol; 2002 Jan; 86(1):75-9. PubMed ID: 11801508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure.
    Jampel HD; Bacharach J; Sheu WP; Wohl LG; Solish AM; Christie W;
    Am J Ophthalmol; 2002 Dec; 134(6):863-71. PubMed ID: 12470755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma.
    Sponsel WE; Paris G; Trigo Y; Pena M
    Am J Ophthalmol; 2002 Oct; 134(4):552-9. PubMed ID: 12383812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of latanoprost and unoprostone when used alone or in combination for open-angle glaucoma.
    Saito M; Takano R; Shirato S
    Am J Ophthalmol; 2001 Oct; 132(4):485-9. PubMed ID: 11589867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular pressure fluctuations in response to the water-drinking provocative test in patients using latanoprost versus unoprostone.
    Susanna R; Medeiros FA; Vessani RM; Giampani J; Borges AS; Jordão ML
    J Ocul Pharmacol Ther; 2004 Oct; 20(5):401-10. PubMed ID: 15650515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of intraocular pressure-lowering effect of prostaglandin F2 -alpha analogues, latanoprost, and unoprostone isopropyl.
    Kobayashi H; Kobayashi K; Okinami S
    J Glaucoma; 2001 Dec; 10(6):487-92. PubMed ID: 11740220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.
    Parrish RK; Palmberg P; Sheu WP;
    Am J Ophthalmol; 2003 May; 135(5):688-703. PubMed ID: 12719078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraocular pressure-lowering efficacy of latanoprost in patients with normal-tension glaucoma or primary open-angle glaucoma.
    Tamada Y; Taniguchi T; Murase H; Yamamoto T; Kitazawa Y
    J Ocul Pharmacol Ther; 2001 Feb; 17(1):19-25. PubMed ID: 11322634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%.
    Eisenberg DL
    Am J Ophthalmol; 2001 Sep; 132(3):448-9. PubMed ID: 11554383
    [No Abstract]   [Full Text] [Related]  

  • 15. Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%.
    Alward WL
    Am J Ophthalmol; 2001 Sep; 132(3):449-51. PubMed ID: 11554384
    [No Abstract]   [Full Text] [Related]  

  • 16. Substituting latanoprost (Xalatan) for isopropyl unoprostone (Rescula) in monotherapy and combination therapy.
    Tsukamoto H; Yokoyama T; Okada K; Okada M; Mochizuki H; Mishima HK
    Acta Ophthalmol Scand; 2000 Oct; 78(5):604-5. PubMed ID: 11037926
    [No Abstract]   [Full Text] [Related]  

  • 17. A preliminary risk-benefit assessment of latanoprost and unoprostone in open-angle glaucoma and ocular hypertension.
    Eisenberg DL; Camras CB
    Drug Saf; 1999 Jun; 20(6):505-14. PubMed ID: 10392667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial.
    DuBiner HB; Mroz M; Shapiro AM; Dirks MS;
    Clin Ther; 2001 Dec; 23(12):1969-83. PubMed ID: 11813932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.
    Noecker RS; Dirks MS; Choplin NT; Bernstein P; Batoosingh AL; Whitcup SM;
    Am J Ophthalmol; 2003 Jan; 135(1):55-63. PubMed ID: 12504698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.